Costa Brava seeks representation on MedQuist board

By Lisa Kerner

Charlotte, N.C., Dec. 13 - MedQuist Inc. investors led by Costa Brava Partnership III LP filed an amended preliminary proxy statement with the Securities and Exchange Commission in regards to the solicitation of proxies for the election of Costa Brava's Andrew R. Siegel and Seth W. Hamot to the company's board.

The investor is also seeking the election of Douglas M. Gleason, Douglas E. Lingon, Alok Mohan and Jay Scollins to MedQuist's board at the company's next annual meeting.

Other than Siegel, the filers beneficially own 1,938,821 shares, or 5.2%, of MedQuist's common stock. Siegel beneficially owns 2,000 shares, or less than 1%, of the Mt. Laurel, N.J., medical transcription technology and services company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.